Why is BioNtech SE important to traders?
Learn all about BioNTech, with information on the company’s history and share price journey, its share trading hours, and how to trade BioNTech shares with Capital.com.
Learn more about BioNtech SETrade BioNtech SE - BNTX CFD
Add to favourite- Summary
- Historical Data
Trading сonditions
| Spread | 0.41 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024124% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001901% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
Key Stats
| Prev. Close | 102.04 |
| Open | 102.34 |
| 1-Year Change | 3.64% |
| Day's Range | 101.47 - 102.41 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Nov 20, 2024 | 102.04 | -4.09 | -3.85% | 106.13 | 106.97 | 100.97 |
| Nov 19, 2024 | 106.39 | 3.93 | 3.84% | 102.46 | 107.87 | 101.21 |
| Nov 18, 2024 | 101.20 | 1.53 | 1.54% | 99.67 | 102.37 | 98.20 |
| Nov 15, 2024 | 98.63 | -2.89 | -2.85% | 101.52 | 102.74 | 94.41 |
| Nov 14, 2024 | 101.52 | -9.91 | -8.89% | 111.43 | 115.85 | 101.46 |
| Nov 13, 2024 | 111.17 | 5.56 | 5.26% | 105.61 | 113.07 | 105.43 |
| Nov 12, 2024 | 105.61 | -2.70 | -2.49% | 108.31 | 108.68 | 105.50 |
| Nov 11, 2024 | 108.45 | -3.00 | -2.69% | 111.45 | 111.69 | 107.45 |
| Nov 8, 2024 | 110.01 | -0.17 | -0.15% | 110.18 | 115.20 | 109.93 |
| Nov 7, 2024 | 106.95 | 1.11 | 1.05% | 105.84 | 110.27 | 105.06 |
| Nov 6, 2024 | 106.44 | -4.62 | -4.16% | 111.06 | 111.91 | 102.47 |
| Nov 5, 2024 | 110.08 | 2.11 | 1.95% | 107.97 | 111.05 | 107.95 |
| Nov 4, 2024 | 108.45 | -2.23 | -2.01% | 110.68 | 114.95 | 107.14 |
| Nov 1, 2024 | 111.43 | 0.00 | 0.00% | 111.43 | 113.71 | 109.55 |
| Oct 31, 2024 | 112.75 | -0.33 | -0.29% | 113.08 | 113.50 | 110.13 |
| Oct 30, 2024 | 113.87 | 0.41 | 0.36% | 113.46 | 114.50 | 110.75 |
| Oct 29, 2024 | 113.63 | 1.27 | 1.13% | 112.36 | 115.56 | 112.25 |
| Oct 28, 2024 | 112.08 | 2.43 | 2.22% | 109.65 | 113.63 | 109.26 |
| Oct 25, 2024 | 110.35 | -0.90 | -0.81% | 111.25 | 111.99 | 109.57 |
| Oct 24, 2024 | 110.95 | 0.30 | 0.27% | 110.65 | 113.20 | 110.36 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trade commission
0
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
Leverage
20:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Open
Close
Short Long
Biontech SE Company profile
Discover the latest BioNTech stock price today with our interactive streaming chart.
Founded in 2008, BioNTech is an innovative biotechnology company from Germany, specialising in the research, development and producing of active individualised immunotherapies. The company adheres to a patient-specific approach to treatment of serious diseases, such as cancer.
BioNTech shares a vision that every patient’s tumour is unique. It means that each patient’s treatment should be individualised. To implement the scientists’ ideas into practice, BioNTech has developed pioneering therapeutics for cancer and other rare and infectious diseases.
Headquartered in Mainz, Germany, the company is aimed at becoming the world’s leading biotechnology company for individialised cancer treatment. By 2020, BioNTech had more than 440 patients treated across 17 tumour types. The company has more than 1,300 employees and seven pharmaceutical partners.
In August 2018, the company partnered with the US pharmaceutical giant Pfizer Inc to develop mRNA-based vaccines for preventing influenza. In September 2019, BioNTech started working on the development of tuberculosis and HIV programmes and preclinical vaccine and immunotherapy candidates for the prevention of tuberculosis and HIV infections under an agreement with the Bill & Melinda Gates Foundation.
BioNTech stock floated on the NASDAQ stock exchange through a $150m initial public offering (IPO) in October 2019. Since then the BNTX stock quote has been traded on the US market.
In November 2020, BioNTech and Pfizer triggered the strongest wave of optimism on the stock market after they announced that their Covid-19 vaccine showed 90 per cent effectiveness during the phase-three clinical trials. The BioNTech share price soared 14 per cent the day after the announcement.
In 2019, BioNTech reported total revenues of about €109m. According to the estimates from Morgan Stanley, BioNTech and Pfizer can make around $13bn from vaccine sales, getting $6.5bn each if these estimates are correct.
Looking closely at the BioNTech stock price chart in 2020, we can see that BNTX stock has been trading in a range of $18.60-$115. Since the large sell-off in March 2020, the BioNTech SE (BNTX) stock quote grew from $28.55 on March 12, 2020, to $112.76 on November 10, 2020, which is a growth of 294 per cent.
Follow the BioNTech share price live on our interactive share price chart and build your own forecast for the famous German biotechnology company. Follow the latest BioNTech share news and spot the best levels to open profitable CFD trades at Capital.com.
| Industry: | Bio Therapeutic Drugs |
An der Goldgrube 12
MAINZ
RHEINLAND-PFALZ 55131
DE
News
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
15:17, 18 November 2024
Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target
Can Shiba Inu reinvent itself to become a worthy long-term investment?
08:36, 15 November 2024
Trump trades charge as Bitcoin hits $US80,000
Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.
10:48, 13 November 2024
Australian jobs data expected to point to solid labour market conditions
Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.
10:16, 13 November 2024
FOMC cuts interest rates as expected and sticks to its line on future policy
The FOMC cut interest rates by 25 basis points at its November meeting, aligning with expectations. Wall Street hit record highs following the decision, with tech stocks leading the rally. Markets are pricing in a probable December cut amid resilient economic indicators.
13:33, 8 November 2024
FOMC and BOE preview: further rate cuts expected
Both the Federal Reserve and the Bank of England are expected to cut rates further when they meet later this week.
14:14, 5 November 2024
RBA meeting preview: No change to policy expected as inflation fight continues
The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.
13:35, 4 November 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com